French researchers have identified a blood test that could revolutionize how amyotrophic lateral sclerosis (ALS) is diagnosed ...

The first-ever platform trial for ALS tested four drugs simultaneously, creating a faster path to finding treatments for a ...

United Healthcare Services Inc. failed to defeat a proposed class action saying it wrongly refuses to cover noninvasive ...

ALS impacts tens of thousands of people across the United States, and hundreds in Arizona. There's research being done in the Valley that can hopefully help contribute to ending ALS.

Ivor Elrifi, CEO of Tiziana Life Sciences, expressed enthusiasm about this milestone, stating, "We are excited to initiate this important clinical study with the support of the ALS Association grant.

Tetramethylpyrazine nitrone was safe for people with amyotrophic lateral sclerosis (ALS), but neither a high nor low daily ...

The late R&B artist, who died at the age of 88 in 2025, battled a major health issue in her final years. Learn about her ALS ...

A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...

Diagnosing ALS is a challenge, but new research has found a highly effective way to detect and track the disease using blood ...

Tiziana Life Sciences (TLSA) announced the submission of its Investigational New Drug, IND, application to the U.S. Food and Drug ...